Implant company in sale talks

Nobel Biocare state that discussions are “at a very early stage”

Swiss dental implant company Nobel Biocare has confirmed that it has been approached by potential buyers with a view to acquiring the company.

However, the manufacturer insisted that any talks of a sale are in the early stages and may not go any further.

Bloomberg News reported on Tuesday (29 July) that the company had been exploring a sale for some time and is currently working with Goldman Sachs on a potential transaction.

In response, Nobel Biocare release the following statement: “The company confirms that it has been approached by third parties with a potential interest in acquiring the company.

“Nobel Biocare is in discussions, which are at a very early stage and may or may not result in any transaction.

“The company will provide an update, if and when appropriate.”

Nobel Biocare was founded in 1981 and is listed on the Swiss stock exchange. Shares in the Zurich-based company rose rapidly following the Bloomberg report, closing up 15.5 per cent at 16 Swiss francs and valuing the company at 1.98 billion francs (€1.63bn).